JP2005500375A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005500375A5 JP2005500375A5 JP2003520377A JP2003520377A JP2005500375A5 JP 2005500375 A5 JP2005500375 A5 JP 2005500375A5 JP 2003520377 A JP2003520377 A JP 2003520377A JP 2003520377 A JP2003520377 A JP 2003520377A JP 2005500375 A5 JP2005500375 A5 JP 2005500375A5
- Authority
- JP
- Japan
- Prior art keywords
- nerve
- graft
- chondroitin sulfate
- degrading enzyme
- neural tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000005036 nerve Anatomy 0.000 claims 86
- 238000000034 method Methods 0.000 claims 67
- 230000001537 neural effect Effects 0.000 claims 36
- 210000001519 tissue Anatomy 0.000 claims 32
- 102000004190 Enzymes Human genes 0.000 claims 27
- 108090000790 Enzymes Proteins 0.000 claims 27
- 230000000593 degrading effect Effects 0.000 claims 27
- 229940088598 enzyme Drugs 0.000 claims 27
- 102000005598 Chondroitin Sulfate Proteoglycans Human genes 0.000 claims 26
- 108010059480 Chondroitin Sulfate Proteoglycans Proteins 0.000 claims 26
- 238000000338 in vitro Methods 0.000 claims 11
- 238000012258 culturing Methods 0.000 claims 10
- 208000028389 Nerve injury Diseases 0.000 claims 5
- 230000008764 nerve damage Effects 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 230000001737 promoting effect Effects 0.000 claims 5
- 239000003106 tissue adhesive Substances 0.000 claims 5
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 claims 4
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 claims 4
- 210000003169 central nervous system Anatomy 0.000 claims 4
- 239000003937 drug carrier Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 210000001428 peripheral nervous system Anatomy 0.000 claims 4
- 230000003376 axonal effect Effects 0.000 claims 3
- 230000008014 freezing Effects 0.000 claims 3
- 238000007710 freezing Methods 0.000 claims 3
- 208000014674 injury Diseases 0.000 claims 3
- 230000009545 invasion Effects 0.000 claims 3
- 108010003272 Hyaluronate lyase Proteins 0.000 claims 2
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 claims 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims 2
- 208000027418 Wounds and injury Diseases 0.000 claims 2
- 230000000735 allogeneic effect Effects 0.000 claims 2
- 230000006378 damage Effects 0.000 claims 2
- 229960002773 hyaluronidase Drugs 0.000 claims 2
- 210000000944 nerve tissue Anatomy 0.000 claims 2
- 210000002241 neurite Anatomy 0.000 claims 2
- 238000003522 neurite outgrowth assay Methods 0.000 claims 2
- 230000002093 peripheral effect Effects 0.000 claims 2
- 238000009877 rendering Methods 0.000 claims 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims 1
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 1
- 108090000819 Chondroitin-sulfate-ABC endolyases Proteins 0.000 claims 1
- 102000037716 Chondroitin-sulfate-ABC endolyases Human genes 0.000 claims 1
- 101710106625 Chondroitinase-AC Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 102000000424 Matrix Metalloproteinase 2 Human genes 0.000 claims 1
- 108010016165 Matrix Metalloproteinase 2 Proteins 0.000 claims 1
- 102000001776 Matrix metalloproteinase-9 Human genes 0.000 claims 1
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 claims 1
- 102100024588 Podocalyxin-like protein 2 Human genes 0.000 claims 1
- 108091010857 Podocalyxin-like protein 2 Proteins 0.000 claims 1
- 102000016611 Proteoglycans Human genes 0.000 claims 1
- 108010067787 Proteoglycans Proteins 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 229940059329 chondroitin sulfate Drugs 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 210000000981 epithelium Anatomy 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 210000000578 peripheral nerve Anatomy 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000011550 stock solution Substances 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 230000008733 trauma Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31187001P | 2001-08-13 | 2001-08-13 | |
| US60/311,870 | 2001-08-13 | ||
| PCT/US2002/025922 WO2003015612A2 (en) | 2001-08-13 | 2002-08-13 | Materials and methods to promote repair of nerve tissue |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005500375A JP2005500375A (ja) | 2005-01-06 |
| JP2005500375A5 true JP2005500375A5 (enExample) | 2005-12-22 |
| JP4749667B2 JP4749667B2 (ja) | 2011-08-17 |
Family
ID=23208862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003520377A Expired - Lifetime JP4749667B2 (ja) | 2001-08-13 | 2002-08-13 | 神経組織の修復を促進するための材料および方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (8) | US20030077258A1 (enExample) |
| EP (1) | EP1425390B1 (enExample) |
| JP (1) | JP4749667B2 (enExample) |
| KR (1) | KR20040021697A (enExample) |
| CN (1) | CN1553952A (enExample) |
| AT (1) | ATE543509T1 (enExample) |
| BR (1) | BR0211888A (enExample) |
| CA (1) | CA2455827C (enExample) |
| ES (1) | ES2378227T3 (enExample) |
| HU (1) | HUP0500634A3 (enExample) |
| IL (1) | IL160188A0 (enExample) |
| MX (1) | MXPA04001334A (enExample) |
| WO (1) | WO2003015612A2 (enExample) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6670179B1 (en) * | 2001-08-01 | 2003-12-30 | University Of Kentucky Research Foundation | Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth |
| CA2455827C (en) * | 2001-08-13 | 2015-06-09 | University Of Florida Research Foundation, Inc. | Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan |
| GB0205022D0 (en) * | 2002-03-04 | 2002-04-17 | Univ Cambridge Tech | Materials and methods for the treatment of cns damage |
| EP1575548B1 (en) * | 2002-05-04 | 2011-03-09 | Acorda Therapeutics, Inc. | Compositions and methods for promoting neuronal outgrowth |
| US7163545B2 (en) * | 2002-07-29 | 2007-01-16 | Mayo Foundation For Medical Education And Research | Spinal cord surgical implant |
| DE60337009D1 (de) * | 2002-08-15 | 2011-06-16 | Acorda Therapeutics Inc | Chimärisches protein |
| US7135027B2 (en) * | 2002-10-04 | 2006-11-14 | Baxter International, Inc. | Devices and methods for mixing and extruding medically useful compositions |
| US7959914B2 (en) | 2003-05-16 | 2011-06-14 | Acorda Therapeutics, Inc. | Methods of reducing extravasation of inflammatory cells |
| MX351062B (es) * | 2003-05-16 | 2017-09-29 | Acorda Therapeutics Inc | Proteinas de fusion para el tratamiento del snc. |
| MXPA05012305A (es) * | 2003-05-16 | 2006-04-18 | Acorda Therapeutics Inc | Composiciones y metodos para el tratamiento de lesiones del snc. |
| EP3211084B1 (en) | 2003-05-16 | 2019-03-27 | Acorda Therapeutics, Inc. | Proteoglycan degrading mutants for treatment of cns |
| JP4773976B2 (ja) * | 2004-01-30 | 2011-09-14 | エモリー ユニバーシティ | 神経再生を促進する材料および方法 |
| AU2005244933B2 (en) * | 2004-05-18 | 2011-08-04 | Acorda Therapeutics, Inc. | Methods of purifying chondroitinase and stable formulations thereof |
| WO2005122734A2 (en) * | 2004-06-14 | 2005-12-29 | The Research Foundation Of State University Of New York | Nanosphere/microsphere delivery system for the treatment of spinal cord injury |
| US20060041318A1 (en) * | 2004-08-19 | 2006-02-23 | Shannon Donald T | Laminar skin-bone fixation transcutaneous implant and method for use thereof |
| JP5189985B2 (ja) | 2005-09-26 | 2013-04-24 | アコーダ セラピューティクス、インク． | コンドロイチナーゼａｂｃｉ変異体を用いた組成物およびその使用方法 |
| US7599774B2 (en) * | 2006-03-10 | 2009-10-06 | Gm Global Technology Operations, Inc. | Method and system for adaptively compensating closed-loop front-wheel steering control |
| CA2652675C (en) * | 2006-05-19 | 2015-11-24 | Aichi Prefecture | Chondroitin sulfate degradation to ameliorate brain damage induced by hypoxia |
| AU2007307736C1 (en) | 2006-10-10 | 2014-04-10 | Acorda Therapeutics, Inc. | Compositions and methods of using chondroitinase ABCI mutants |
| WO2008149428A1 (ja) * | 2007-06-05 | 2008-12-11 | Glycoscience Laboratories, Inc. | 自己免疫疾患、炎症及び神経疾患の治療剤及び予防剤 |
| WO2009124170A1 (en) * | 2008-04-04 | 2009-10-08 | The Cleveland Clinic Foundation | Use of epineural sheath grafts for neural regeneration and protection |
| US9095569B2 (en) | 2008-04-18 | 2015-08-04 | Collplant Ltd. | Methods of generating and using procollagen |
| EP2405920A1 (en) | 2009-03-06 | 2012-01-18 | Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research | Novel therapy for anxiety |
| US8758374B2 (en) | 2010-09-15 | 2014-06-24 | University Of Utah Research Foundation | Method for connecting nerves via a side-to-side epineurial window using artificial conduits |
| WO2012177238A1 (en) * | 2011-06-21 | 2012-12-27 | Tamara Tennison | System and method of repairing of neural networks |
| EP2768425B1 (en) | 2011-10-17 | 2018-11-14 | University of Utah Research Foundation | Methods and devices for connecting nerves |
| US10842494B2 (en) | 2011-10-17 | 2020-11-24 | University Of Utah Research Foundation | Methods and devices for connecting nerves |
| WO2013102048A2 (en) | 2011-12-30 | 2013-07-04 | University Of Miami | Regenerative tissue matrix |
| CN102716470B (zh) * | 2012-06-28 | 2015-02-04 | 中国人民解放军第三军医大学第三附属医院 | 一种治疗周围神经损伤的药物组合物 |
| WO2016145452A1 (en) | 2015-03-12 | 2016-09-15 | Myoscience, Inc. | Methods and systems for preventing neuroma formations |
| US9690975B2 (en) * | 2015-05-28 | 2017-06-27 | Axogen Corporation | Quantitative structural assay of a nerve graft |
| US11513039B2 (en) | 2015-05-28 | 2022-11-29 | Axogen Corporation | Nerve culture system |
| US11156595B2 (en) * | 2015-05-28 | 2021-10-26 | Axogen Corporation | Organotypic DRG-peripheral nerve culture system |
| CN105239137A (zh) * | 2015-10-29 | 2016-01-13 | 无锡桥阳机械制造有限公司 | 一种电镀工艺 |
| US10064938B2 (en) | 2016-03-11 | 2018-09-04 | University Of Wyoming | Localized immunosuppression of allografts for peripheral nerve repair |
| ES3059911T3 (en) * | 2016-12-12 | 2026-03-24 | Univ California | Biomimetic implants |
| WO2018127554A1 (en) * | 2017-01-06 | 2018-07-12 | Novahep Ab | Methods of preparing bioengineered or bioprinted organ or tissue, and uses thereof |
| WO2019054407A1 (ja) * | 2017-09-15 | 2019-03-21 | 東洋紡株式会社 | 神経保護材 |
| WO2019099394A1 (en) * | 2017-11-15 | 2019-05-23 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Systems and methods for reconstruction of nerve defects |
| JP7456934B2 (ja) | 2018-04-12 | 2024-03-27 | アクソジェン コーポレーション | 予め作製された付着点を有する組織移植片 |
| WO2020014889A1 (zh) * | 2018-07-18 | 2020-01-23 | 中山大学附属第一医院 | 四肢主干神经的仿生修复体模型的建立方法 |
| CN108992709B (zh) * | 2018-07-27 | 2021-05-14 | 山东省眼科研究所 | 一种脱细胞神经基质材料及其制备方法和应用 |
| US11376219B2 (en) | 2018-07-30 | 2022-07-05 | University Of Wyoming | Localized immunosuppression of allografts for peripheral nerve repair |
| US20200054467A1 (en) * | 2018-08-20 | 2020-02-20 | Zakary Llamo-Cohen | Method for establishing an electrically conductive artificial nerve |
| US11147558B2 (en) * | 2018-11-15 | 2021-10-19 | Axogen Corporation | Materials and methods for nerve repair with animal-sourced grafts |
| JP2022507364A (ja) * | 2018-11-15 | 2022-01-18 | アクソジェン コーポレーション | 動物由来の神経移植片を用いた神経修復のための材料および方法 |
| CN109893680B (zh) * | 2019-03-07 | 2021-10-08 | 宁波光远致信生物科技有限公司 | 一种修复纤维膜、修复套接管及其制备方法和用途 |
| CA3163996A1 (en) | 2019-12-30 | 2021-07-08 | Renerva, Llc | Extracellular matrix systems, devices, and methods of deployment |
| TW202233262A (zh) * | 2020-10-22 | 2022-09-01 | 美商阿克松根股份有限公司 | 成束神經移植物、製造成束神經移植物之方法以及使用成束神經移植物之治療方法 |
| WO2022256401A1 (en) * | 2021-06-01 | 2022-12-08 | Xenotherapeutics, Inc. | Xenogeneic nerve transplants and methods |
| CA3232270A1 (en) * | 2021-09-30 | 2023-04-06 | Renerva, Llc | Nerve graft systems, devices, and methods |
| WO2023212531A1 (en) * | 2022-04-27 | 2023-11-02 | Board Of Regents, The University Of Texas System | Polyethylene glycol-fusion in nerve repair |
| CN115944784B (zh) * | 2023-01-04 | 2024-12-03 | 南通大学 | 一种细胞化纤维支架及其制备方法和应用 |
| CN116570770B (zh) * | 2023-07-12 | 2023-11-07 | 天新福（北京）医疗器材股份有限公司 | 一种双层冻干管状物及其制备方法与应用 |
| AU2024363792A1 (en) * | 2023-10-17 | 2026-04-23 | Axogen Corporation | Methods for analyzing a processed nerve graft |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US77258A (en) * | 1868-04-28 | Improvement in weeding-hoe | ||
| US40112A (en) * | 1863-09-29 | Improvement in metallic cartridges | ||
| US4778467A (en) * | 1984-04-25 | 1988-10-18 | The University Of Utah | Prostheses and methods for promoting nerve regeneration and for inhibiting the formation of neuromas |
| US4696816A (en) * | 1985-11-07 | 1987-09-29 | Brown Mark D | Method for treating intervertebral disc displacement with enzymes |
| US4933185A (en) | 1986-09-24 | 1990-06-12 | Massachusetts Institute Of Technology | System for controlled release of biologically active compounds |
| US4877029A (en) * | 1987-03-30 | 1989-10-31 | Brown University Research Foundation | Semipermeable nerve guidance channels |
| US4870966A (en) * | 1988-02-01 | 1989-10-03 | American Cyanamid Company | Bioabsorbable surgical device for treating nerve defects |
| CA2071898A1 (en) | 1989-10-27 | 1991-04-28 | Diane M. Snow | Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
| CA2066658A1 (en) | 1989-10-31 | 1991-05-01 | David Muir | Inhibitor of laminin neurite promoting activity |
| ZA912770B (en) * | 1990-04-16 | 1992-01-29 | Bethesda Eye Inst | Enzymatic disinsertion of vitreous body |
| US5173295A (en) * | 1990-10-05 | 1992-12-22 | Advance Biofactures Of Curacao, N.V. | Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor |
| US5231580A (en) | 1991-04-01 | 1993-07-27 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Automated method and apparatus for determining characteristics of nerve fibers |
| US5496718A (en) | 1992-06-26 | 1996-03-05 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Chondroitinase ABC isolated from proteus vulgaris ATCC 6896 |
| JP3419811B2 (ja) | 1993-02-24 | 2003-06-23 | マルハ株式会社 | コンドロイチナーゼ遺伝子 |
| EP0716610B1 (en) | 1993-08-26 | 2006-05-17 | Genetics Institute, LLC | Human bone morphogenetic proteins for use in neural regeneration |
| US5916557A (en) | 1993-11-12 | 1999-06-29 | The Trustees Of Columbia University In The City Of New York | Methods of repairing connective tissues |
| AU7949394A (en) * | 1993-11-19 | 1995-06-06 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human medulloblastomatous cell |
| EP0756636A4 (en) * | 1994-04-22 | 1997-12-17 | American Cyanamid Co | CHONDROITINASES I AND II, PROCESSES FOR THEIR PREPARATION AND THEIR USE |
| US6093563A (en) * | 1994-07-08 | 2000-07-25 | Ibex Technologies R And D, Inc. | Chondroitin lyase enzymes |
| US5997863A (en) | 1994-07-08 | 1999-12-07 | Ibex Technologies R And D, Inc. | Attenuation of wound healing processes |
| US6214987B1 (en) * | 1994-09-02 | 2001-04-10 | Andrew C. Hiatt | Compositions for enzyme catalyzed template-independent formation of phosphodiester bonds using protected nucleotides |
| US6057137A (en) * | 1994-10-06 | 2000-05-02 | Regents Of The University Of Minnesota | Tissue-equivalent rods containing aligned collagen fibrils and schwann cells |
| US5487756A (en) * | 1994-12-23 | 1996-01-30 | Simon Fraser University | Implantable cuff having improved closure |
| EP0807185B9 (en) | 1995-01-30 | 2002-12-11 | Lunamed AG | Antitumor preparations containing a lipoteichoic acid from steptococcus |
| US6033660A (en) * | 1995-05-10 | 2000-03-07 | Genentech, Inc. | Method of treating a nervous system injury with cultured schwann cells |
| US5830468A (en) | 1995-05-17 | 1998-11-03 | The New York Blood Center, Inc. | Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase |
| US6231608B1 (en) | 1995-06-07 | 2001-05-15 | Crosscart, Inc. | Aldehyde and glycosidase-treated soft and bone tissue xenografts |
| JP3093974B2 (ja) | 1995-06-27 | 2000-10-03 | 住友ベークライト株式会社 | 神経細胞用培養液、その製造方法及びこれを用いる神経細胞の培養方法 |
| US6313265B1 (en) * | 1995-07-24 | 2001-11-06 | The Scripps Research Institute | Neurite outgrowth-promoting polypeptides containing fibronectin type III repeats and methods of use |
| DE19530556C1 (de) | 1995-07-28 | 1996-09-05 | Will Prof Dr Minuth | Verfahren zum Kultivieren von Zellen des menschlichen oder tierischen Körpers |
| US5866120A (en) | 1995-11-22 | 1999-02-02 | Advanced Corneal Systems, Inc. | Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase |
| SE9602879D0 (sv) * | 1996-07-26 | 1996-07-26 | Henrich Cheng | Medical device |
| AU6897198A (en) | 1997-04-11 | 1998-11-11 | Beth Israel Deaconess Medical Center | Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions |
| DE69829605T2 (de) | 1997-05-02 | 2006-02-09 | Seikagaku Corp. | Chondroitinase enthaltende Zusammensetzungen |
| US6448076B2 (en) | 1998-09-15 | 2002-09-10 | The Regents Of The University Of Michigan | Method for chemically acellularizing a biological tissue sample |
| MXPA01003538A (es) * | 1998-10-06 | 2005-09-08 | Rush Presbyterian St Luke | Metodo para el tratamiento de quimionucleolisis. |
| US20030068815A1 (en) | 1999-02-11 | 2003-04-10 | Stone Kevin R. | Sterilized xenograft tissue |
| US6267786B1 (en) | 1999-02-11 | 2001-07-31 | Crosscart, Inc. | Proteoglycan-reduced soft tissue xenografts |
| WO2001035977A2 (en) | 1999-11-17 | 2001-05-25 | Ibex Technologies, Inc. | Attenuation of tumor growth, metastasis and angiogenesis by use of chondroitin sulfate degrading enzymes |
| CA2393186A1 (en) | 1999-12-02 | 2001-06-07 | Ibex Technologies, Inc. | Attenuation of fibroblast proliferation |
| AU5790801A (en) * | 2000-01-21 | 2001-07-31 | Biomarin Pharmaceutical Inc. | Flavobacterium heparinum expression system |
| DE60130769T2 (de) | 2000-07-28 | 2008-07-17 | Dainippon Sumitomo Pharma Co., Ltd. | Förderer der nervenregeneration die als aktiven bestandteil einen semaphorinhemmer enthalten |
| CA2455827C (en) | 2001-08-13 | 2015-06-09 | University Of Florida Research Foundation, Inc. | Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan |
| EP1761550A2 (en) | 2004-05-26 | 2007-03-14 | California Institute of Technology | Small molecule stimulators of neuronal growth |
-
2002
- 2002-08-13 CA CA2455827A patent/CA2455827C/en not_active Expired - Lifetime
- 2002-08-13 AT AT02763451T patent/ATE543509T1/de active
- 2002-08-13 US US10/218,315 patent/US20030077258A1/en not_active Abandoned
- 2002-08-13 HU HU0500634A patent/HUP0500634A3/hu unknown
- 2002-08-13 ES ES02763451T patent/ES2378227T3/es not_active Expired - Lifetime
- 2002-08-13 BR BR0211888-2A patent/BR0211888A/pt not_active IP Right Cessation
- 2002-08-13 CN CNA028178866A patent/CN1553952A/zh active Pending
- 2002-08-13 JP JP2003520377A patent/JP4749667B2/ja not_active Expired - Lifetime
- 2002-08-13 US US10/218,316 patent/US7851447B2/en not_active Expired - Lifetime
- 2002-08-13 MX MXPA04001334A patent/MXPA04001334A/es active IP Right Grant
- 2002-08-13 EP EP02763451A patent/EP1425390B1/en not_active Expired - Lifetime
- 2002-08-13 IL IL16018802A patent/IL160188A0/xx unknown
- 2002-08-13 WO PCT/US2002/025922 patent/WO2003015612A2/en not_active Ceased
- 2002-08-13 US US10/218,864 patent/US6972168B2/en not_active Expired - Lifetime
- 2002-08-13 KR KR10-2004-7002131A patent/KR20040021697A/ko not_active Withdrawn
-
2004
- 2004-03-29 US US10/812,776 patent/US7732200B2/en not_active Expired - Lifetime
-
2008
- 2008-08-12 US US12/190,359 patent/US20080299536A1/en not_active Abandoned
-
2010
- 2010-12-13 US US12/966,540 patent/US8986733B2/en not_active Expired - Fee Related
-
2013
- 2013-02-25 US US13/776,606 patent/US9402868B2/en not_active Expired - Fee Related
-
2016
- 2016-08-02 US US15/226,409 patent/US10441681B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bearzi et al. | PlGF–MMP9-engineered iPS cells supported on a PEG–fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium | |
| Maden et al. | Model systems for regeneration: the spiny mouse, Acomys cahirinus | |
| Yao et al. | Recent development and biomedical applications of decellularized extracellular matrix biomaterials | |
| Muheremu et al. | Past, present, and future of nerve conduits in the treatment of peripheral nerve injury | |
| Simon et al. | Cambium cell stimulation from surgical release of the periosteum | |
| Fishman et al. | Stem cell-based organ replacements—airway and lung tissue engineering | |
| US8728809B2 (en) | Use of pressure waves for stimulation, proliferation, differentiation and post-implantation viability of stem cells | |
| Bittner et al. | Typical and atypical properties of peripheral nerve allografts enable novel strategies to repair segmental-loss injuries | |
| US20210046125A1 (en) | Decellularized tissues, hydrogels thereof, and uses thereof | |
| Takaku et al. | In vivo cell tracking by bioluminescence imaging after transplantation of bioengineered cell sheets to the knee joint | |
| RU2160112C1 (ru) | Способ приготовления клеточного трансплантата из фетальных тканей | |
| US20030026788A1 (en) | Use of extracellular matrix tissue to preserve cultured cell phenotype | |
| US20140079673A1 (en) | Treatment of ischemia using stem cells | |
| US20190184061A1 (en) | Composition for cartilage regeneration and preparing thereof | |
| DE10026789A1 (de) | Knorpelersatz und Verfahren zu dessen Herstellung | |
| Martínez-Santamaría et al. | Skin bioengineering: preclinical and clinical applications | |
| Wang et al. | Repairing peripheral nerve injury using tissue engineering techniques | |
| Müller‐Ehmsen et al. | Cellular cardiomyoplasty—a novel approach to treat heart disease | |
| AU738028B2 (en) | Dermal sheath tissue in wound healing | |
| CN1297320C (zh) | 毛囊重建系统 | |
| CN104667348A (zh) | 一种含有海藻酸钠的药用组合物及其制备方法 | |
| Sutar et al. | An overview of stem cell therapy | |
| Arun et al. | Nerve regeneration in vascularized composite allotransplantation: current strategies and future directions | |
| US20250075187A1 (en) | Medium composition for preparation of intestinal organoid | |
| Im et al. | Comparison of the regeneration induced by acellular nerve allografts processed with or without chondroitinase in a rat model |